Changes of serum concentrations of brain-derived neurotrophic factor (bdnf) during treatment with venlafaxine and mirtazapine: Role of medication and response to treatment

Pharmacopsychiatry

Volumn 46, Issue 2, 2013, Pages 54-58

  Deuschle, M ^a   Gilles, M ^a   Scharnholz, B ^a   Lederbogen, F ^a   Lang, U E ^b   Hellweg, R ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

antidepressant; brain derived neurotrophic factor (BDNF); depression; remission

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; LORAZEPAM; MIRTAZAPINE; VENLAFAXINE; ZOLPIDEM;

ADULT; AGED; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL PATIENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84875223501     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0032-1321908     Document Type: Article

References (42)

1. Duman R. S., Monteggia L. M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry: 2006; 59 1116 1127
2. Castrén E., Rantamäki T. Role of brain-derived neurotrophic factor in the aetiology of depression: implications for antidepressant treatment. CNS Drugs: 2010; 24 1 7
3. Nibuya M., Morinobu S., Duman R. Regulation of BDNF and TrkB messenger RNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neuroscience: 1995; 15 7539 7547
4. Sartorius A., Hellweg R., Litzke J. et al. Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatments in rats. Pharmacopsychiatry: 2009; 42 270 276
5. Shirayama Y., Chen AC H., Nakagawa S. Brain-derived neurotrophic factor produces antidepressant effects in behavioural models of depression. J Neuroscience: 2002; 22 3251 3261 (Pubitemid 35379212)
6. Cooke J. D., Grover L. M., Spangler P. R. Venlafaxine treatment stimulates expression of BDNF protein in frontal cortex and inhibits long-term potentiation in hippocampus. Neuroscience: 2009; 162 1411 1419
7. Xu H. Y., Chen Z., He J. et al. Synergistic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus. Hippocampus: 2006; 16 551 559 (Pubitemid 43942103)
8. Rogoz Z., Skuza G., Legutko B. Repeated treatment with mirtazapine induces brain-derived neurotrophic factor gene expression in rats. J Physiol Pharmacol: 2005; 56 661 671 (Pubitemid 43127561)
9. Dias B. G., Banerjee S. B., Duman R. S. et al. Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain. Neuropharmacol: 2003; 45 553 563 (Pubitemid 36936988)
10. Russo-Neustadt A. A., Alejandre H., Garcia C. et al. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology: 2004; 29 2189 2199 (Pubitemid 39578909)
11. Altar C. A., Whitehead R. E., Chen R. Y. et al. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry: 2003; 54 703 709 (Pubitemid 37281386)
12. Jacobsen JP R., Mork A. The effect of citalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and correlation to 5-HT and 5-HIAA levels. Brain Res: 2004; 1024 183 192 (Pubitemid 39286729)
13. Schulte-Herbrüggen O., Fuchs E., Abumaria N. et al. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. J Neurosci Res: 2009; 87 2551 2560
14. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression and antidepressant medications: meta-analysis and implications. Biol Psychiatry: 2008; 64 527 532
15. Molendijk M. L., Bus BA A., Spinhoven P. et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry: 2011; 16 1088 1095
16. Matrisciano F., Bonaccorso S., Ricciardi A. et al. Changes in BDNF serum levels in patients with major depression disorder after 6 months treatment with sertraline, escitalopram or venlafaxine. J Psychiat Res: 2008; 43 247 254
17. Basterzi A. D., Yazici K., Aslan E. et al. Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients. Prog Neuro Psychopharmacol Biol Psych: 2009; 33 281 285
18. Aydemir C., Yalcin E. S., Aksaray S. et al. Brain-derived neurotrophic factor (BDNF) changes in serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry: 2006; 30 1256
19. Gervasoni N., Aubry J. M., Bondolfi G. et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology: 2005; 51 234 238 (Pubitemid 40976406)
20. Gonul A. S., Akdeniz F., Taneli F. et al. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psych Clin Neurosci: 2005; 255 381 386 (Pubitemid 43029827)
21. Piccinni A., Marazziti D., Catena M. et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord: 2008; 105 279 283 (Pubitemid 350245688)
22. Huang T. L., Lee C. T., Liu Y. L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res: 2007; 42 521 525
23. Hellweg R., Ziegenhorn A., Heuser I. et al. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry: 2008; 41 66 71 (Pubitemid 351427525)
24. Möller H. J. Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment. W J Biol Psychiatry: 2008; 9 102 114
25. Hellweg R., Lohmann P., Huber R. et al. Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signalling as a biological marker of early impairment. Learn Mem: 2006; 13 63 71 (Pubitemid 43204397)
26. Ziegenhorn A. A., Schulte-Herbrüggen O., Danker-Hopfe H. et al. Serum neurotrophins - a study on the time course and influencing factors in a large old age sample. Neurobiol Aging: 2006; 28 1436 1445 (Pubitemid 47090171)
27. Satomura E., Baba H., Nakano Y. et al. Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression. J Affect Disord: 2011; 135 232 325
28. Russo-Neustadt A., Beard R. C., Cotman C. W. Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology: 1999; 21 679 682 (Pubitemid 29486636)
29. Duman R. Depression: a case of neuronal life and death? Biol Psychiatry: 2004; 56 140 145 (Pubitemid 38969145)
30. Malberg J. E., Eisch A. J., Nestler E. J. et al. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci: 2000; 20 9104 9110 (Pubitemid 32042912)
31. Deuschle M., Hamann B., Meichel C. et al. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol: 2003; 23 201 205 (Pubitemid 36368799)
32. Scharnholz B., Weber-Hamann B., Lederbogen F. et al. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. Psychiatry Res: 2010; 177 109 113
33. Karege F., Bondolfi G., Gervasoni N. et al. Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry: 2005; 57 1068 1072 (Pubitemid 40613035)
34. Karege F., Perret G., Bondolfi G. et al. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res: 2002; 109 143 148 (Pubitemid 34258493)
35. Pan W., Banks W. A., Fasold M. B. et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology: 1998; 37 1553 1561 (Pubitemid 28550429)
36. Zhang Y., Gu F., Chen J. et al. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res: 2010; 1366 141 148
37. Schins A., Hamulyák K., Scharpé S. et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci: 2004; 76 637 650 (Pubitemid 39573394)
38. Tharmapathy P., Selheim F., Odegaard K. et al. Venlafaxine treatment stimulates blood platelet activity. J Clin Psychopharmacol: 2000; 20 589 590
39. Serra-Millàs M., López-Vílchez I., Navarro V. et al. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology: 2011; 216 1 8
40. Trajkovska V., Marcussen A. B., Vinberg M. et al. Measurement of brain-derived neurotrophic factor: methodological aspects and demographic data. Brain Res Bull: 2007; 73 143 149 (Pubitemid 46722657)
41. Sen S., Nesse R. M., Stoltenberg S. F. et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology: 2003; 28 397 401
42. Balu D. T., Hoshaw B. A., Malberg J. E. et al. Differential regulation of central BDNF protein levels by antidepressants and non-antidepressant drug treatments. Brain Res: 2008; 1211 37 43